Clin2
NCT04838678Possibly a fitRecruiting

Testing a new blood-pressure approach in obesity-related hypertension

HypertensionObesity

Part of Heart & circulation, Hormones & metabolism clinical trials.

This early-stage study tests a new way to help control high blood pressure that is linked to obesity. It may help people whose blood pressure is high based on a 24-hour blood pressure monitor.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
100 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are 18 to 55 years old
  • If you are not obese: your BMI must be under 30 and you still have high blood pressure
  • If you are obese: your BMI must be 30 or higher and you have high blood pressure
  • Your high blood pressure must be confirmed by a 24-hour ambulatory (wearable) blood pressure monitor
  • You do not have major heart or blood-vessel disease other than high blood pressure
  • You do not have kidney disease, diabetes, or a history of smoking

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05312892Recruiting· Phase 1/Phase 2
Study for weight-related hormone signals in people with high blood pressure

This early-phase study looks at how the body’s “fight-or-flight” signals may be involved in weight gain (obesity) and high blood pressure. It may help researchers understand the biology and guide future treatments.

Nashville, Tennessee
NCT05590546Not yet recruiting
Study brain-to-body signaling in people with obesity

This study looks at how signals from the nervous system may affect the body in people with obesity. You may be eligible if you meet specific measurements for waist size and do not have certain medical conditions or recent smoking history.

NCT07566390Recruiting· Phase 1
Testing a new weight-loss medicine in healthy adults

This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.

Glendale, California
NCT07567001Recruiting· Phase 3
Testing NNC0487-0111 for Heart Failure and Obesity

This study tests whether a new medication called NNC0487-0111 can help people with heart failure who also have obesity. Researchers will compare it to a placebo (inactive pill) to see if it improves heart function and overall health.

Alexander City, Alabama
NCT07754474Not yet recruiting· Phase 1
Testing a new medicine for overweight or obesity

This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.

Mannheim
NCT06482853Recruiting· Early Phase 1
Heart effects of a natural protein in obesity and high blood pressure

This study tests whether a natural protein called angiotensin-(1-7) can improve heart health in people with obesity and high blood pressure. It may help researchers find new ways to treat these conditions together.

Hershey, Pennsylvania

Hear when a new High blood pressure trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.